Segovia Fernando D, Ream Sarah, Dang The, Chaganti Bhanu T, Ortega Andrew J, Rhee Seunghong, Borges Jorge C
Internal Medicine, Texas Tech University Health Sciences Center, El Paso, USA.
Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, USA.
Cureus. 2022 Aug 5;14(8):e27722. doi: 10.7759/cureus.27722. eCollection 2022 Aug.
The prothrombotic nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been well-established since the start of the global coronavirus disease 2019 (COVID-19) pandemic. Mesenteric artery thrombosis and acute mesenteric ischemia are, on their own, rare occurrences and often present with fatal gastrointestinal (GI) pathologies requiring quick identification and intervention by the clinician to improve clinical outcomes. SARS-CoV-2 infection can present with acute GI pathologies and warrants further investigation regarding anticoagulation therapy in COVID-19 positive patients. We report on a 64-year-old woman infected with SARS-CoV-2 who presented with superior mesenteric artery thrombosis and acute intestinal ischemia.
自2019年全球冠状病毒病(COVID-19)大流行开始以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的促血栓形成特性已得到充分证实。肠系膜动脉血栓形成和急性肠系膜缺血本身较为罕见,常伴有致命的胃肠道(GI)病变,需要临床医生迅速识别并进行干预,以改善临床结局。SARS-CoV-2感染可伴有急性GI病变,因此有必要对COVID-19阳性患者的抗凝治疗进行进一步研究。我们报告了一名64岁感染SARS-CoV-2的女性,她出现了肠系膜上动脉血栓形成和急性肠缺血。